These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Ferrara N; Hillan KJ; Gerber HP; Novotny W Nat Rev Drug Discov; 2004 May; 3(5):391-400. PubMed ID: 15136787 [No Abstract] [Full Text] [Related]
16. Venous thromboembolism in patients with cancer. Part II. Current treatment strategies. Viale PH; Schwartz RN Clin J Oncol Nurs; 2004 Oct; 8(5):465-9. PubMed ID: 15515280 [TBL] [Abstract][Full Text] [Related]
17. Targeted therapies in breast cancer: challenging questions from oncology nurses. Becze E ONS Connect; 2007; 22(8 Suppl):31-2. PubMed ID: 17824554 [No Abstract] [Full Text] [Related]
18. Recurrent indolent NHL: new strategies for treatment. Amen K ONS Connect; 2007; 22(8 Suppl):57-8. PubMed ID: 17824567 [No Abstract] [Full Text] [Related]
19. Prescription drugs uses and effects. Corticosteroids. Jordan S; Griffiths H Nurs Stand; 2004 Mar 17-23; 18(27):2p.. PubMed ID: 15061025 [No Abstract] [Full Text] [Related]
20. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies. Zondor SD; Medina PJ Ann Pharmacother; 2004; 38(7-8):1258-64. PubMed ID: 15187215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]